Financial Ratios | Lyka Labs Ltd. | R Wadiwala Securities Pvt Ltd

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE74.69-2.61 (-3.38 %)
PREV CLOSE (Rs.) 77.30
OPEN PRICE (Rs.) 76.97
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1329
TODAY'S LOW / HIGH (Rs.)74.24 77.32
52 WK LOW / HIGH (Rs.)73.56 167.1
NSE74.46-2.62 (-3.4 %)
PREV CLOSE( Rs. ) 77.08
OPEN PRICE (Rs.) 79.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 74.46 (2)
VOLUME 45729
TODAY'S LOW / HIGH(Rs.) 74.00 79.00
52 WK LOW / HIGH (Rs.)72.2 167.19

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)2.24-0.75-4.3013.59-4.03
   CEPS(Rs)4.123.080.3219.45-0.62
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)29.0117.869.124.65-8.99
   Tax Rate(%)28.69-180.600.1435.1128.66
Margin Ratios
   Core EBITDA Margin(%)12.9514.1218.0952.1222.82
   EBIT Margin(%)9.673.56-1.4040.9013.67
   Pre Tax Margin(%)8.03-0.84-14.1530.53-16.40
   PAT Margin (%)5.73-2.36-14.1319.81-11.70
   Cash Profit Margin (%)10.629.161.0728.75-2.05
Performance Ratios
   ROA(%)4.76-1.70-7.8021.40-5.58
   ROE(%)9.76-6.02-63.630.000.00
   ROCE(%)10.063.26-1.0056.688.95
   Asset Turnover(x)0.830.720.551.080.48
   Sales/Fixed Asset(x)0.790.700.561.020.44
   Working Capital/Sales(x)6.668.638.02-4.12-4.15
Efficiency Ratios
   Fixed Capital/Sales(x)1.261.421.800.982.27
   Receivable days92.3377.3375.6525.5135.37
   Inventory Days29.0427.1229.7111.7623.36
   Payable days88.8287.52104.0092.01161.35
Valuation Parameters
   PER(x)44.970.000.009.980.00
   PCE(x)24.5134.43322.976.97-42.22
   Price/Book(x)3.485.9311.4729.17-2.89
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.873.614.102.592.66
   EV/Core EBITDA(x)19.6823.3818.864.8610.82
   EV/EBIT(x)29.63101.43-293.506.3319.49
   EV/CE(x)2.803.213.252.711.32
   M Cap / Sales2.603.153.452.000.86
Growth Ratio
   Net Sales Growth(%)24.5519.47-52.05125.0240.27
   Core EBITDA Growth(%)17.46-15.17-80.40385.973765.48
   EBIT Growth(%)238.57404.20-101.64573.04128.21
   PAT Growth(%)402.7480.08-134.21480.9883.89
   EPS Growth(%)398.4082.52-131.67437.5380.91
Financial Stability Ratios
   Total Debt/Equity(x)0.370.962.589.76-6.30
   Current Ratio(x)1.451.341.360.530.58
   Quick Ratio(x)1.181.091.210.440.50
   Interest Cover(x)5.900.81-0.113.940.45
   Total Debt/Mcap(x)0.110.160.220.332.18